Concretely, in diabetes patients, hyperglycemia, insulin resistance and altered insulin signaling, neuroinflammation, cerebral microvascular injury, and accumulation of cerebral amyloid and tau proteins are among the postulated pathophysiological mechanisms underlying cognitive decline [193]. Here, MAPT is linked to diabetes mellitus.